Bronchoalveolar lavage macrophage-lymphocyte clusters in granulomatous disease are linked to lymphocytosis

Sarcoidosis Vasculitis and Diffuse Lung Diseases

Volumn 17, Issue 2, 2000, Pages 174-180

  Bauer, Roslyn A ^a   Sawyer, Richard T ^a,b   Daniloff, Elaine ^a   Balkissoon, Ronald ^a,b   Rose, Cecile S ^a,b,c   Newman, Lee S ^a,b,c  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

Beryllium; Chronic beryllium disease; Granulomatous disease; Macrophage lymphocyte clusters; Sarcoidosis

Indexed keywords

BERYLLIUM;

ADULT; ARTICLE; BERYLLIOSIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; FEMALE; HUMAN; HUMAN CELL; LUNG GRANULOMATOSIS; LUNG LAVAGE; LYMPHOCYTE; LYMPHOCYTOSIS; MACROPHAGE; MALE; PRIORITY JOURNAL; SARCOIDOSIS;

ADULT; AGED; BERYLLIOSIS; BRONCHOALVEOLAR LAVAGE; CELL AGGREGATION; FEMALE; GRANULOMATOUS DISEASE, CHRONIC; HUMANS; LYMPHOCYTES; MACROPHAGES, ALVEOLAR; MALE; MIDDLE AGED; SARCOIDOSIS, PULMONARY;

EID: 0034047752     PISSN: 11240490     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Newman LS, Rose CS, Maier LA: Sarcoidosis. N Engl J Med 1997; 336: 1224-34.
2. Maier L, Newman LS: 1998; In Environmental and Occupational Medicine, 3rd Ed, Rom, WN (ed), Lippincott Raven Publishers: Philadelphia: pp 1021-34
3. 3 production by T lymphocytes and alveolar macrophages recovered by lavage from normocalcemic patients with tuberculosis. J Clin Invest 1990; 85: 1588-93.
4. Lyons, DJ, Gautam A, Clark J, et al: Lymphocyte macrophage interactions: Peripolesis of human alveolar macrophages. Ear Respir J 1992; 5: 59-66.
5. Danel C, Dewar A, Corrin B, Turner-Warwick M, Chretien J: Untrastructural changes in bronchoalveolar lavage cells in sarcoidosis and comparison with the tissue granuloma. Am J Pathol 1983; 112: 7-17.
6. Herscowitz HB: In Defence of the Lung: Paradoxical role of the pulmonary alveolar macrophage. Ann Allergy 1985; 55: 634-48.
7. Van Maarsseveen TC, De Groot J, Stam J, Van Diest PJ: Peripolesis in alveolar sarcoidosis. Am Rev Respir Dis 1993; 147: 1259-63.
8. Sulitzeanu D, Kleinman R, Benezra D, Gery I: Cellular interactions and the secondary response in vitro. Nature New Biology 1971: 229: 254-5.
9. Hepburn B, McDuffle FC, Ritts RE Jr: The macrophage-lymphocyte rosette. Its increased incidence among cells from rheumatoid synovial fluid. Arthritis Rheum 1974; 17: 1026-32.
10. Ina Y, Takada K, Yamamoto M, Morishita M, Miyachi A: Antigen-presenting capacity in patients with sarcoidosis. Chest 1990; 98: 911-6.
11. McFarland W, Heilman D: Lymphocyte foot appendage: Its role in lymphocyte function and immunologic reactions. Nature 1965; 205: 887-8.
12. Takemura T, Rom WN, Ferrans VJ, Crystal RG: Morphologic characterization of alveolar macrophages from patients with occupational exposure to inorganic particles. Am Rev Respir Dis 1989; 140: 1674-85.
13. Newman LS, Kreiss K, King TE Jr, Seay S, Campbell PA: Pathologic and immunologic alterations in early stages of beryllium disease: Re-examination of disease definition and natural history. Am Rev Respir Dis 1989; 139: 1479-86.
14. Mroz MM, Kreiss K, Lezotte DC, Campbell PA, Newman LS: Re-examination of the blood lymphocyte transformation test in the diagnosis of chronic beryllium disease. J Allergy Clin Immunol 1991; 88: 54-60.
15. Newman LS: Significance of the blood beryllium lymphocyte proliferation test (BeLPT). Environ Health Perspect 1996;104: 953-6.
16. Newman .S, Lloyd J, Daniloff EA: The natural history of beryllium sensitization and chronic beryllium disease. Environ Health Perspect 1996; 104: 937-43.
17. Watters LC, Schwartz MI, Cherniak RM: Idiopathic pulmonary fibrosis: pretreatment bronchoalveolar lavage cellular constituents and their relationship with lung histopathology and clinical response to therapy. Am Rev Respir Dis 1987; 135: 696-704.
18. King TE Jr: 1992; In Bronchoalveolar Lavage, Baughman RP (ed), Mosby-Year Book Inc.: St. Louis, MO: pp 18-21.
19. Lipsky PE, Rosenthal AS: Macrophage-lymphocyte interaction. Characteristics of the antigen-independent-binding of guinea pig thymocytes and lymphocytes to syngeneic macrophages. J Exp Med 1973; 138: 900-23.
20. Lipsky PE, Rosenthal AS: Macrophage-lymphocyte interaction: Antigen-independent binding of guinea pig lymph node lymphocytes by macrophases. J Immunol 1975; 115: 440-5.
21. Ziprin RL, Rowler SR, Witzel DA: Alveolar macrophage-lymphocyte rosette formation: Failure of levamisole to alter activity. Infect Immun 1977; 16: 720-2.
22. Newman LS, Bobka C, Shumacher B, et al: Compartmentalized immune response reflects clinical severity of beryllium disease. Am J Respir Crit Care Med 1994; 150: 134-42.
23. Van Maarsseveen TC, Mullink H, Stam J, De Groot J: Macrophage-T suppressor cell interference in the lungs of steroid-treated sarcoidosis patients. Am Rev Respir Dis 1991; 143: 839-43.
24. Saltini C, Winestock K, Kirby M, Pinkston, P, Crystal RG: Maintenance of alveolitis in patients with chronic beryllium disease by beryllium-specific helper T cells. N Engl J Med 1989; 320: 1103-9.
25. Epstein PE, Dauber JH, Rossman MD, Daniele RP: Bronchoalveolar lavage in a patient with chronic berylliosis: evidence for hypersensitivity pneumonitis. Ann Intern Med 1982; 97: 213-6.
26. Lem VM, Lipscomb MF, Weissler JC, et ak: Bronchoalveolar cells from sarcoid patients demonstrate enhanced antigen presentation. J Immunol 1985; 135: 1766-71.
27. Striz I, Wang YM, Kalaycioglu O, Costabel U: Expression of alveolar macrophage adhesion molecules in pulmonary sarcoidosis. Chest 1992; 102: 882-6.